Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiqun Chen

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Iscience|June 16, 2025
Comparing AI and human decision-making mechanisms in daily collaborative experimentsLinghao Wang, Zheyuan Jiang, Chenke Hu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 19, 2023
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's DiseasePranay Srivastava, Shuhei Nishiyama, Fang Zhou, et al.
Plos One|January 24, 2017
Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's DiseaseKsenia V Kastanenka, Steven S Hou, Naomi Shakerdge, et al.
Annals of Neurology|February 15, 2019
Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseRachit Bakshi, Eric A Macklin, Robert Logan, et al.
Ebiomedicine|August 7, 2025
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJackson G Schumacher, Xinyuan Zhang, Eric A Macklin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJackson G Schumacher, Xinyuan Zhang, Eric A Macklin, et al.
Molecular Neurodegeneration|February 24, 2022
Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's diseaseWaijiao Cai, Pranay Srivastava, Danielle Feng, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 11, 2025
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progressionPeter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 25, 2022
Traditional Chinese medicine Pingchan granule for motor symptoms and functions in Parkinson's disease: A multicenter, randomized, double-blind, placebo-controlled studySi-Chun Gu, Rong Shi, Chen Gaoag, et al.
Progress in Neurobiology|February 6, 2023
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's diseaseWaijiao Cai, Kazumasa Wakamatsu, Fabio A Zucca, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Iscience|June 16, 2025
Comparing AI and human decision-making mechanisms in daily collaborative experimentsLinghao Wang, Zheyuan Jiang, Chenke Hu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 19, 2023
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's DiseasePranay Srivastava, Shuhei Nishiyama, Fang Zhou, et al.
Plos One|January 24, 2017
Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's DiseaseKsenia V Kastanenka, Steven S Hou, Naomi Shakerdge, et al.
Annals of Neurology|February 15, 2019
Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseRachit Bakshi, Eric A Macklin, Robert Logan, et al.
Ebiomedicine|August 7, 2025
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJackson G Schumacher, Xinyuan Zhang, Eric A Macklin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJackson G Schumacher, Xinyuan Zhang, Eric A Macklin, et al.
Molecular Neurodegeneration|February 24, 2022
Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's diseaseWaijiao Cai, Pranay Srivastava, Danielle Feng, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 11, 2025
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progressionPeter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 25, 2022
Traditional Chinese medicine Pingchan granule for motor symptoms and functions in Parkinson's disease: A multicenter, randomized, double-blind, placebo-controlled studySi-Chun Gu, Rong Shi, Chen Gaoag, et al.
Progress in Neurobiology|February 6, 2023
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's diseaseWaijiao Cai, Kazumasa Wakamatsu, Fabio A Zucca, et al.
Pageof 6